Verbatim response from Perplexity
Ozempic without insurance is usually around $1,000 to $1,200 per month at retail/list price, but some manufacturer cash-pay programs now lower that to $199 for the first two fills for eligible new patients on lower-dose pens, then $349 to $499 per month depending on dose.[2][3][5]
People afford it mainly through a few routes: manufacturer savings cards for people with qualifying commercial insurance, Novo Nordisk’s direct cash/self-pay program for uninsured or self-pay patients, and patient assistance programs for some low-income or government-insured patients.[1][3][5][6]
The most common ways people reduce the cost are:
- Ozempic savings card: eligible commercially insured patients may pay as little as $25 per month.[2][3][5]
- NovoCare/self-pay pricing: eligible uninsured or self-pay patients may get $199/month initially, then $349–$499/month depending on dose.[1][5]
- Patient Assistance Program: some uninsured, Medicare, or otherwise eligible patients can receive Ozempic at no cost if they meet income and eligibility rules.[3][6]
- Pharmacy discount tools/coupons: some people use discount programs like GoodRx, though the price is still often far above the manufacturer’s self-pay offer.[2][9]
A practical takeaway: if you’re paying full retail, Ozempic is commonly a four-figure monthly medication; if you qualify for manufacturer programs, the out-of-pocket cost can drop dramatically.[1][2][5]
If you want, I can also break down which savings option fits uninsured vs. commercially insured vs. Medicare in a simple table.